Official websites use .govA.govwebsite belongs to an official
                            government organization in the United States.

Secure .gov websites use HTTPSAlock(LockLocked padlock icon) orhttps://means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.

Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/.

Correction: Crit Care (2024) 28:43810.1186/s13054-024-05214-5.

Following the publication of the original article [1], the author reported that due to an error the Competing Interests section was incomplete and that affiliations 6-8 were incorrectly included.

RH was active in the Advisory Board of Shionogi, the supplier of cefiderocol. JS received speaker’s honorarium from Gilead, Pfizer and bioMérieux.

The Competing Interests section has been updated in this correction article and the original article [1] has been corrected.